M&A Deal Summary |
|
---|---|
Date | 2021-06-17 |
Target | T3S Technologies - Bacterial Secretion Platform |
Sector | Life Science |
Buyer(s) | Vectron Biosolutions |
Sellers(s) | T3S Technologies |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Vectron Biosolutions provides the life science industry with superior technologies and solutions for robust and cost-efficient production of recombinant proteins in E. coli and other bacteria through a combination of experienced life science researchers, state-of-the-art laboratory facilities, a proprietary technology platform, and skillful management. Vectron Biosolutions was founded in 2008 and is based in Trondheim, Norway.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Utah) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2021) | 1 of 1 |
T3S Technologies is a developer of genetically engineered bacterial cells designed to provide treatment of chronic disease, based in Salt Lake City, Utah.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Utah) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2021) | 1 of 1 |